Can I order a blood test to determine a patient’s ABO and Rh blood type?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Type Testing: Direct Answer

Yes, you can and should order a blood test to determine a patient's ABO and Rh blood type when clinically indicated, particularly before any potential transfusion or in specific clinical scenarios such as pregnancy, surgery with bleeding risk, or trauma. 1

When Blood Type Testing is Essential

Pre-Transfusion Requirements

  • Blood samples must be collected and labeled at the patient's side by appropriately trained personnel to minimize wrong-blood-in-tube events and prevent potentially fatal ABO incompatibility. 1
  • Positive patient identification is paramount - minimum identifiers include surname, forename, date of birth, and hospital unique identification number. 1
  • All patients receiving blood transfusion must wear a patient identification band before any transfusion episode. 1

Sample Validity and Timing

  • If a patient has received a transfusion or been pregnant within the previous 3 months, the blood sample is only valid for 72 hours (from collection to subsequent transfusion). 1
  • For patients without recent transfusion or pregnancy, historical samples may be used in conjunction with current samples if proper electronic verification exists. 1

Two-Sample Recommendation

  • Two samples are not always required if a suitable historical sample exists on file. 1
  • Where patient identification confirms the historical sample is from the same patient, it may serve as the "group-check" sample for ABO-compatible RBC issue. 1
  • If no historical sample with proper electronic transmission exists, two samples will be required. 1

Specific Clinical Scenarios

Surgical Patients

  • For elective surgery with potential transfusion need, baseline type and screen testing should be completed at least 1 day before surgery to ensure compatible blood availability. 2
  • A type and screen method (ABO/Rh typing plus antibody screening without crossmatching) is recommended for most patients undergoing cesarean section, abdominal hysterectomy, and vaginal hysterectomy. 3
  • If antibody screen is negative, crossmatching can be completed in 20 minutes if transfusion becomes necessary, or type-specific blood available after 15-second saline spin. 3

Pregnancy-Related Indications

  • All Rh D-negative pregnant individuals at risk for Rh D alloimmunization require blood typing to determine need for Rho(D) immune globulin prophylaxis. 4
  • For pregnant women presenting to emergency departments with vaginal bleeding or abdominal pain, blood typing determines Rh status for potential RhIG administration. 5
  • Pregnant women who report "yes, definitely" knowing their blood type are 99.1% accurate for Rh status identification, though formal testing remains standard practice. 5

Emergency/Trauma Settings

  • Rapid ABO and RhD testing demonstrates 99.5% concordance with reference laboratory testing and 99.3% sensitivity, potentially useful for emergency department determination of RhD type to guide blood product selection during resuscitation. 6
  • This is particularly important for women of childbearing potential to avoid D-alloimmunization risk from RhD-positive blood products. 6

Common Pitfalls to Avoid

  • Never transfuse without proper patient identification - wrong-blood-in-tube events remain a critical safety concern. 1
  • Do not rely on samples older than 72 hours for patients with recent transfusion or pregnancy history - antibody formation can occur rapidly. 1
  • Ensure samples are labeled at bedside, not pre-labeled - this is a fundamental safety requirement. 1
  • For unknown patient identity situations, implement alternative identification systems with at least one unique identifier before collecting blood samples. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Guideline No. 448: Prevention of Rh D Alloimmunization.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.